← Leaderboards
Opher Gileadi
University Of Oxford
$12,500
Attributed
$25,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.5M · FY2009–21$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$22,255,909 · 2
By mechanism
U54$22,230,909 · 1
R03$25,000 · 1
Top collaborators
- Aled M Edwards3 shared
- Stephen Vernon Frye3 shared
- Haian Fu3 shared
- Allan I Levey3 shared
- Frank M Longo3 shared
- Lara M Mangravite3 shared
- Gregory W Carter2 shared
- Alessandro Vindigni1 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposStructureProteinsDesignInterestBaseIn VitroPharmaceutical PreparationsAnimal ModelFundingBiologyBiologicalAntibodiesAffectEvaluationGuide RnaDrug MarketCell LineAmyloidDisease ProgressionDrug DevelopmentDrug DiscoveryDrug TargetingCandidate Validation
Grant awards (4)
Open Drug Discovery Center for Alzheimer's Disease$7,311,958
U54 · FY2021 · AG
Open Drug Discovery Center for Alzheimer's Disease$7,420,073
U54 · FY2020 · AG
Open Drug Discovery Center for Alzheimer's Disease$7,498,878
U54 · FY2019 · AG
Small-molecule inhibitors of the human RECQ1 and Bloom DNA helicases$25,000
R03 · FY2009 · MH · contact PI